180 Life Sciences Corp. - notizie pubblicate 234 - letture 8.947
180 LIFE SCIENCES CORP.
Proxy Statement - Form DEF 14A
United states securities and exchange commission washington, d.c. 20549 __________________________________ schedule 14a __________________________________ proxy statement pursuant ...
180 LIFE SCIENCES CORP.
Adalimumab Found To Be a Likely Cost-Effective Treatment for Early-Stage Dupuytren’s Disease - Form 8-K
Adalimumab found to be a likely cost-effective treatment for early-stage dupuytren's disease palo alto, calif., november 15, 2022 -- 180 life sciences corp. (nasdaq: atnf) ("1 ...
180 LIFE SCIENCES CORP.
CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren’s Disease
Correction: adalimumab found to be a likely cost-effective treatment for early-stage dupuytren's disease november 15, 2022 12:37pm est download as pdf palo alto, calif., nov. 15, 2 ...
180 LIFE SCIENCES CORP.
Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytren’s Disease
Adalimumab found to be a likely cost-effective treatment for early-stage dupuytren's disease november 15, 2022 8:00am est download as pdf palo alto, calif., nov. 15, 2022 (globe ne ...
180 LIFE SCIENCES CORP.
Quarterly Report for Quarter Ending September 30, 2022 (Form 10-Q)
United states securities and exchange commission washington, d. c. 20549 form 10-q (mark one) ☒quarterly report pursuant to section 13 or 15(d) of the securities exchange act of ...
180 LIFE SCIENCES CORP.
Quarterly Earnings Document
United states securities and exchange commission washington, d. c. 20549 form 10-q (mark one) quarterly report pursuant to section013 or 15(d) of the securities exchange act of 193 ...
180 LIFE SCIENCES CORP.
Preliminary Proxy Statement - Form PRE 14A
United states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 (amendment no. ...
180 LIFE SCIENCES CORP.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
180 LIFE SCIENCES CORP.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
180 LIFE SCIENCES CORP.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
180 LIFE SCIENCES CORP.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
180 LIFE SCIENCES CORP.
Life Sciences with the University of Oxford Announce the Enrollment of the First Patient in a Trial of Anti-TNF for People with Early-Stage Frozen Shoulder - Form 8-K
180 life sciences with the university of oxford announce the enrollment of the first patient in a trial of anti-tnf for people with early-stage frozen shoulder palo alto, calif., a ...
180 LIFE SCIENCES CORP.
180 Life Sciences with the University of Oxford Announce the Enrollment of the First Patient in a Trial of Anti-TNF for People with Early-Stage Frozen Shoulder
180 life sciences with the university of oxford announce the enrollment of the first patient in a trial of anti-tnf for people with early-stage frozen shoulder august 22, 2022 8:30 ...
180 LIFE SCIENCES CORP.
Corporate Presentation
Nasdaq: atnf leading research into solving one of the world's largest drivers of disease: inflammation corporate presentation july 2022 disclaimer this presentation is for informat ...
180 LIFE SCIENCES CORP.
Statement of Changes in Beneficial Ownership (Form 4)
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti